Pegloticase every two weeks (biweekly) vs placebo
Withdrawals due to adverse events · participants with tophi in gout
Pegloticase every two weeks (biweekly) probably leads to higher number of participant withdrawals due to adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- RR 7.59 [1.04, 55.55]1 study · 128 participantsModerate